![Melissa Haskell](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Melissa Haskell currently works at Rallybio Corp., as Vice President, Non-Clinical Toxicology & Research from 2023.
Ms. Haskell also formerly worked at Alexion Pharmaceuticals, Inc., as Executive Director.
Ms. Haskell received her undergraduate degree from the University of Massachusetts Amherst.
| Unternehmen | Position | Beginn |
|---|---|---|
| RALLYBIO CORPORATION | Technik-/Wissenschafts-/F&E-Leiter | 01.02.2023 |
| Unternehmen | Position | Ende |
|---|---|---|
| ALEXION PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 4 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops life-changing therapies for people living with rare disorders | Health Technology |
College of Veterinary Medicine (North Carolina)
 College of Veterinary Medicine (North Carolina) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rallybio Corp.
 Rallybio Corp. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that engages in research, development and commercialization of therapies for patients with severe & rare diseases | Health Technology |
University of Massachusetts Amherst
 University of Massachusetts Amherst Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
